Single-cell Analysis Market Analysis, Segments, Key Players, Drivers, Trends and Forecast 2022

The Single-Cell Analysis Marketis expected to reach USD 3.59 Billion by 2022 from USD 1.67 Billion in 2017, at a CAGR of 16.5%.

According to a new market research report “Single-Cell Analysis Market by Product (Consumables and Instruments), Cell Type (Human and Animal), Technique (Flow Cytometry, NGS, PCR, and Mass Spectrometry), Application (Cancer, Neurology, NIPD, IVF, and CTCs), End User — Global Forecasts to 2022”, published by MarketsandMarkets™.

Growth of the market is primarily driven by the technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and pharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and increasing incidence and prevalence of chronic and infectious diseases.

Browse 107 market data tables and 42 figures spread through 175 pages and in-depth TOC on “Single-Cell Analysis Market”

http://www.marketsandmarkets.com/Market-Reports/single-cell-analysis-market-171955254.html

Single-Cell Analysis Market

Single-cell Analysis Market, By Cell Type:

• Human Cells
• Animal Cells
• Microbial Cells

Consumables estimated to dominate the market in 2017

Based on the type of products, the Single-Cell Analysis Market is segmented into consumables and instruments. In 2017, the consumables segment is expected to dominate this market, primarily due to requirement of frequent and repeat purchase of these products as compared to instruments, which are considered as a one-time investment.

Single-cell Analysis Market, By Products:

• Consumables
• Beads
• Microplates
• Reagents
• Assay Kits

Download PDF Brochure:http://www.marketsandmarkets.com/pdfdownload.asp?id=171955254

Flow cytometry to have the largest market share in 2017

On the basis of technique, the Single-Cell Analysis Market is segmented into flow cytometry, NGS, PCR, microscopy, mass spectrometry, and other techniques (including single-molecule fluorescence in situ hybridization, micromanipulation, and automated capillary electrophoresis). In 2017, flow cytometry is expected to dominate the market. Wide usage of flow cytometry in single-cell analysis applications is expected to boost the demand for single-cell analysis techniques.

Single-cell Analysis Market, By Technique:

• Flow Cytometry
• NGS
• PCR
• Microscopy
• Mass Spectrometry

Talk To Our Research Analysts:http://www.marketsandmarkets.com/speaktoanalyst.asp?id=171955254

North America to dominate the market followed by Europe

On the basis of the region, the Single-Cell Analysis Market is segmented into North America, Europe, Asia, and RoW. In 2017, North America accounted for the largest share of the market, followed by Europe.

The large share of the North American market is attributed to the factors such as increasing collaborations among prominent players, technological advancements, and expanding biotechnology and pharmaceutical industries. Factors such as increasing incidence of diseases, government support for various research activities, and growing focus on stem cell research and regenerative medicine are expected to fuel the market growth in the European region.

The Single-Cell Analysis Market is highly competitive with the presence of major players. Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Promega Corporation (U.S.), Danaher Corporation (U.S.), General Electric Company (U.K.), Thermo Fisher Scientific Inc. (U.S.), Miltenyi Biotec (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Fluidigm Corporation (U.S.), NanoString Technologies, Inc. (U.S.), Agilent Technologies (U.S.), Abcam Plc (U.S.),

About MarketsandMarkets™ -

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:
 Mr. Shelly Singh
 MarketsandMarkets™ INC.
 630 Dundee Road
 Suite 430
 Northbrook, IL 60062
 USA: +1–888–600–6441
 Email: sales@marketsandmarkets.com